WADA The 2020 Monitoring Program*
The following substances are placed on the 2020 Monitoring Program:
1.) Anabolic agents:
In- and Out-of-Competition: ecdysterone
2.) Beta-2-agonists:
In- and Out-of-Competition: any combination of beta-2-agonists
3.) 2-ethylsulfanyl-1H-benzimidazole (bemitil): In- and Out-of-Competition
4.) Stimulants:
In-Competition only: bupropion, caffeine, nicotine, phenylephrine,
phenylpropanolamine, pipradrol and synephrine
5.) Narcotics:
In-Competition only: codeine, hydrocodone and tramadol
6.) Glucocorticoids:
In-Competition (by routes of administration other than oral,
intravenous, intramuscular or rectal) and Out-of-Competition (all
routes of administration)
* The World Anti-Doping Code (Article 4.5) states: “WADA, in consultation with Signatories and governments, shall establish a monitoring program regarding substances which are not on the Prohibited List, but which WADA wishes to monitor in order to detect patterns of misuse in sport.”